Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3426)
All Articles published online
|
Dec 15, 2003 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lai YC, Shih CY, Jeng CM, Yang SS, Hu JT, Sung YC, Liu HT, Hou SM, Wu CH, Chen TK. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of the portal vein tumor thrombosis. World J Gastroenterol 2003; 9(12): 2666-2670 [PMID: 14669309 DOI: 10.3748/wjg.v9.i12.2666] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i12/2666.htm |
| Number | Citing Articles |
| 1 |
Bazarragchaa Damdinsuren, Hiroaki Nagano, Morito Monden. Combined intra‐arterial 5‐fluorouracil and subcutaneous interferon‐alpha therapy for highly advanced hepatocellular carcinoma. Hepatology Research 2007; 37(s2) doi: 10.1111/j.1872-034X.2007.00191.x
|
| 2 |
XU-ZHENG CHEN, ZHI-YUN CAO, TUAN-SHENG CHEN, YOU-QUAN ZHANG, ZHI-ZHEN LIU, YIN-TAO SU, LIAN-MING LIAO, JIAN DU. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncology Reports 2012; 28(2): 742 doi: 10.3892/or.2012.1834
|
| 3 |
Masafumi Ikeda, Takuji Okusaka, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Hidekazu Yamaura, Yoshitaka Inaba, Yoshito Takeuchi, Mitsuo Satake, Yasuaki Arai. A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemotherapy and Pharmacology 2013; 72(2): 463 doi: 10.1007/s00280-013-2222-x
|
| 4 |
A. Lubienski, M. Simon, K. Lubienski, J. Gellissen, R.-T. Hoffmann, T.F. Jakobs, T. Helmberger. Update Chemoperfusion und -embolisation. Der Radiologe 2007; 47(12): 1097 doi: 10.1007/s00117-007-1587-4
|
| 5 |
Yoshio Katamura, Hiroshi Aikata, Shintaro Takaki, Takahiro Azakami, Tomokazu Kawaoka, Koji Waki, Akira Hiramatsu, Yoshiiku Kawakami, Shoichi Takahashi, Masahiro Kenjo, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. Journal of Gastroenterology 2009; 44(5): 492 doi: 10.1007/s00535-009-0033-y
|
| 6 |
Zi-Han Zhang, Qing-Xin Liu, Wen Zhang, Jing-Qin Ma, Jian-Hua Wang, Jian-Jun Luo, Ling-Xiao Liu, Zhi-Ping Yan. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World Journal of Gastroenterology 2017; 23(43): 7735-7745 doi: 10.3748/wjg.v23.i43.7735
|
| 7 |
MinKe He, ShuYue Liu, ZhiCheng Lai, ZeFeng Du, QiJiong Li, Li Xu, Anna Kan, JianXian Shen, Ming Shi. Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries. Current Opinion in Pharmacology 2023; 70: 102362 doi: 10.1016/j.coph.2023.102362
|
| 8 |
Yoshio Katamura, Hiroshi Aikata, Yuki Kimura, Takahiro Azakami, Tomokazu Kawaoka, Shintaro Takaki, Koji Waki, Akira Hiramatsu, Yoshiiku Kawakami, Shoichi Takahashi, Kazuaki Chayama. Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5‐fluorouracil combined with interferon‐α in a hemodialysis patient. Hepatology Research 2009; 39(4): 415 doi: 10.1111/j.1872-034X.2008.00448.x
|
| 9 |
Yun LU, Li-qun WU, Zheng-hua LÜ, Xin-jian WANG, Jing-yang YANG. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma. Chinese Medical Journal 2007; 120(12): 1042 doi: 10.1097/00029330-200706020-00003
|
| 10 |
MinJie Yang, ZhuTing Fang, ZhiPing Yan, JianJun Luo, LingXiao Liu, Wen Zhang, LinLin Wu, JingQin Ma, QingHui Yang, QingXin Liu. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial. Journal of Cancer Research and Clinical Oncology 2014; 140(2): 211 doi: 10.1007/s00432-013-1568-0
|
| 11 |
Orazio Schillaci, Luca Filippi, Roberta Danieli, Giovanni Simonetti. Single-Photon Emission Computed Tomography/Computed Tomography in Abdominal Diseases. Seminars in Nuclear Medicine 2007; 37(1): 48 doi: 10.1053/j.semnuclmed.2006.07.001
|
| 12 |
Emiko Mikami, Noriatsu Kanno, Yoshiyuki Ueno, Tooru Shimosegawa. Retrospective evaluation of tumor-mass-reduction therapy for the prognosis of recurrent hepatocellular carcinoma. Hepatology International 2007; 1(4): 460 doi: 10.1007/s12072-007-9021-6
|
| 13 |
Kazuto Tajiri, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Ayumu Hosokawa, Hideto Kawabe, Gakuto Tomizawa, Toshiro Sugiyama. Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil. Hepatology Research 2015; 45(7): 755 doi: 10.1111/hepr.12417
|
| 14 |
Bao-Gang Peng, Qiang He, Jia-Ping Li, Fan Zhou. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. The American Journal of Surgery 2009; 198(3): 313 doi: 10.1016/j.amjsurg.2008.09.026
|
| 15 |
Kazuhiro Nouso. Current chemotherapies for advanced hepatocellular carcinoma. Clinical Journal of Gastroenterology 2013; 6(2): 89 doi: 10.1007/s12328-013-0363-4
|
| 16 |
Maria Pleguezuelo, Giacomo Germani, Laura Marelli, Elias Xiruochakis, Maria Misseri, Pinelopi Manousou, Vasiliki Arvaniti, Andrew K Burroughs. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2008; 2(6): 761 doi: 10.1586/17474124.2.6.761
|
| 17 |
Tatsuya Yamashita. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32: 15 doi: 10.2165/1163022-S0-000000000-00000
|
| 18 |
Yu‐Yun SHAO, Chun‐Chieh HUANG, Po‐Chin LIANG, Zhong‐Zhe LIN. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2010; 6(2): 80 doi: 10.1111/j.1743-7563.2010.01287.x
|
| 19 |
Su Ho Kim, Jung Suk Oh, Ho Jong Chun, Byung Gil Choi, Hae Giu Lee. Dual-Port versus Mono-Port Implantation for Intra-Arterial Chemoinfusion Therapy for Treatment of Hepatocellular Carcinoma in Patients with Anatomic Hepatic Artery Variation. Journal of Vascular and Interventional Radiology 2019; 30(1): 23 doi: 10.1016/j.jvir.2018.06.006
|
| 20 |
Matthew S. Strand, Ryan C. Fields. Primary and Metastatic Liver Tumors. 2018; : 333 doi: 10.1007/978-3-319-91977-5_27
|
| 21 |
Shusei Sano, Shinji Nakata, Shuichi Wada, Masatsugu Kuroiwa, Hiroki Sakai, Kei Kusama, Taiichi Machida, Akihito Nishio, Ichiro Ito, Harutsugu Sodeyama. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1772-8
|
| 22 |
Tatsuya Yamashita. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32(S2): 15 doi: 10.1007/BF03265493
|
| 23 |
Li Zhao, Dong-Cheng Mou, Xi-Sheng Leng, Ji-Run Peng, Wan-Xiang Wang, Lei Huang, Shu Li, Ji-Ye Zhu. Expression of cancer-testis antigens in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(14): 2034-2038 doi: 10.3748/wjg.v10.i14.2034
|
| 24 |
Jong Ryul Eun, Heon Ju Lee, Hee Jung Moon, Tae Nyeun Kim, Jae Woon Kim, Jay Chun Chang. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Scandinavian Journal of Gastroenterology 2009; 44(12): 1477 doi: 10.3109/00365520903367262
|
| 25 |
Takashi Niizeki, Shuji Sumie, Takuji Torimura, Junichi Kurogi, Ryoko Kuromatsu, Hideki Iwamoto, Hajime Aino, Masahito Nakano, Atsushi Kawaguchi, Tatsuyuki Kakuma, Michio Sata. Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy. Journal of Gastroenterology 2012; 47(6): 686 doi: 10.1007/s00535-012-0555-6
|
| 26 |
Daniel T Ruan, Robert S Warren. Palliative techniques for hepatic cancer. Surgical Oncology Clinics of North America 2004; 13(3): 505 doi: 10.1016/j.soc.2004.04.003
|
| 27 |
Do Seon Song, Myeong Jun Song, Si Hyun Bae, Woo Jin Chung, Jae Young Jang, Young Seok Kim, Sae Hwan Lee, Jun Yong Park, Hyung Joon Yim, Sung Bum Cho, Soo Young Park, Jin Mo Yang. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Gastroenterology 2015; 50(4): 445 doi: 10.1007/s00535-014-0978-3
|
| 28 |
Christos S. Georgiades, Kelvin Hong, Michael D'Angelo, Jean-Francois H. Geschwind. Safety and Efficacy of Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma and Portal Vein Thrombosis. Journal of Vascular and Interventional Radiology 2005; 16(12): 1653 doi: 10.1097/01.RVI.0000182185.47500.7A
|
| 29 |
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan. Cancers 2012; 4(1): 165 doi: 10.3390/cancers4010165
|
| 30 |
Yu‐Yun Shao, Po‐Chin Liang, Yao‐Ming Wu, Chun‐Chieh Huang, Kai‐Wen Huang, Jason C. Cheng, Chih‐Hung Hsu, Chiun Hsu, Ann‐Lii Cheng, Zhong‐Zhe Lin. A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti‐angiogenic therapy. Liver International 2013; 33(9): 1413 doi: 10.1111/liv.12207
|
| 31 |
Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu. Clinicopathological Predictors of Poor Survival and Recurrence After Curative Resection in Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis. Pathology & Oncology Research 2015; 21(1): 131 doi: 10.1007/s12253-014-9798-2
|
| 32 |
Michihisa Moriguchi, Takeshi Aramaki, Hideyuki Nishiofuku, Rui Sato, Koiku Asakura, Kanji Yamaguchi, Toshihiro Tanaka, Masahiro Endo, Yoshito Itoh. Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis. Liver Cancer 2017; 6(4): 275 doi: 10.1159/000473887
|
| 33 |
Song Gao, Peng-Jun Zhang, Jian-Hai Guo, Hui Chen, Hai-Feng Xu, Peng Liu, Ren-Jie Yang, Xu Zhu. Chemoembolization alone <italic>vs</italic> combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients. World Journal of Gastroenterology 2015; 21(36): 10443-10452 doi: 10.3748/wjg.v21.i36.10443
|
| 34 |
Kiminori Uka, Hiroshi Aikata, Shintaro Takaki, Daiki Miki, Tomokazu Kawaoka, Soo Cheol Jeong, Shoichi Takahashi, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology 2007; 42(10): 845 doi: 10.1007/s00535-007-2099-8
|
| 35 |
Osamu Kimura, Yasuteru Kondo, Tooru Shimosegawa. PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/574180
|
| 36 |
Seigo Ishii, Morio Sato, Tetsuo Sonomura, Katsuyuki Yamada, Hirohiko Tanihata, Hime Ishikawa, Masaki Terada, Shinya Sahara, Nobuyuki Kawai, Masashi Kimura, Ichiro Mori. Optimal Covering Material for Stent-Grafts Placed in the Portal Vein in a Canine Model. CardioVascular and Interventional Radiology 2005; 28(5): 624 doi: 10.1007/s00270-004-0221-3
|
| 37 |
May-Jen Huang, Sien-Sing Yang, Min-Shung Lin, Ching-Shan Huang. Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World Journal of Gastroenterology 2005; 11(6): 797-802 doi: 10.3748/wjg.v11.i6.797
|
| 38 |
Kiminori Uka, Hiroshi Aikata, Shintaro Takaki, Tomokazu Kawaoka, Hiromi Saneto, Daiki Miki, Shoichi Takahashi, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama. Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases. World Journal of Gastroenterology 2008; 14(16): 2602-2608 doi: 10.3748/wjg.14.2602
|
| 39 |
Ik Yoon, Hyung Joon Yim, Jin Nam Kim, Sun Min Park, Jeong Han Kim, Seung Hwa Lee, Hwan Hoon Chung, Hong Sik Lee, Sang Woo Lee, Jai Hyun Choi. A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy. The Korean Journal of Hepatology 2009; 15(1): 90 doi: 10.3350/kjhep.2009.15.1.90
|
| 40 |
Toshihiro Kawai, Takafumi Sugimoto, Yuji Kondo, Miho Kanda, Shinpei Sato, Shuntaro Obi. A case of a super-elderly patient with advanced hepatocellular carcinoma and portal vein invasion successfully treated with hepatic arterial infusion chemotherapy. Kanzo 2018; 59(10): 545 doi: 10.2957/kanzo.59.545
|